← back to search

Jasmin D. Haslbauer

University of Basel · CH
Area of research
Infectious Diseases · Neurology
Research interest
Research interests include COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, SARS-CoV-2 and COVID-19 Research, and Dermatological and COVID-19 studies.
h-index
17
citations
2,152
works
38
NIH funding
primary concept
email

Recent publications

The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution
Cardiovascular Research 2022cited by 62position: middledoi
Inflammation and vascular remodeling in COVID-19 hearts
Angiogenesis 2022cited by 38position: middledoi
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
Histopathology 2020cited by 1,279position: middledoi
Two distinct immunopathological profiles in autopsy lungs of COVID-19
Nature Communications 2020cited by 273position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2020–2020)Thomas Menter · University of Basel2 papers (2020–2020) · 2 papers (2020–2020)Alexandar Tzankov · University Hospital of Basel2 papers (2020–2020)Kirsten D. Mertz · National Institute of Allergy and Infectious Diseases2 papers (2020–2020)Markus Tolnay · Hospital Base2 papers (2020–2020) · 2 papers (2020–2020) · 1 papers (2020–2020)Spasenija Savic · University of Basel1 papers (2020–2020)Viktor H. Koelzer · University of Basel1 papers (2020–2020)Yari Ciani · University of Regensburg1 papers (2020–2020) · 1 papers (2020–2020)Stefano Bassetti · University of Basel1 papers (2020–2020)Nathalie Schwab · University of Lausanne1 papers (2020–2020)Werner Kempf · University of Tübingen1 papers (2020–2020) · 1 papers (2020–2020)Tobias Junt · Novartis (Switzerland)1 papers (2020–2020)Thomas Hoyler · Johannes Gutenberg University Mainz1 papers (2020–2020)Nikolaus Deigendesch · University of Bonn1 papers (2020–2020)Jörg D. Leuppi · University of Basel1 papers (2020–2020)